Radium-223 therapy in symptomatic metastatic castrate resistant prostate cancer (mCRPC) – sequential use post-abiraterone/prednisolone. (October 2019) - Jiang, Xue Yan; Atkinson, Sarah; Cumming, Sam; Burns, Alexander; Pearson, Rachel; Frew, John; McMenemin, Rhona; Azzabi, Ashraf; Leaning, Darren; Pedley, Ian